Atyr Pharma Inc

NASDAQ:LIFE  
8.08
-0.02 (-0.25%)
Earnings Announcements

Atyr Pharma Announces Third Quarter 2021 Results And Provides Corporate Update

Published: 11/10/2021 21:09 GMT
Atyr Pharma Inc (LIFE) - Atyr Pharma Announces Third Quarter 2021 Results and Provides Corporate Update.
Qtrly Loss per Share 42 Cents.
Q3 Earnings per Share View $-0.60 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $2.52 Million
Adjusted EPS is expected to be -$0.35

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.45

More details on our Analysts Page.